Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001899883-26-000023
- form_type
- 8-K
- ticker
- FIP
- cik
- 0001899883
- company_name
- FTAI Infrastructure Inc.
- filed_at
- 2026-05-07T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:33.258302+00:00
- generated_at
- 2026-05-14T22:03:43.740765+00:00
- sec_items
- ["2.02", "9.01"]
- event_type
- other_material
- sentiment
- positive
- materiality_score
- 0.85
- calibrated_materiality_score
- 0.85
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001899883-26-000023
- json_url
- https://secwatch.observer/filing/0001899883-26-000023.json
- markdown_url
- https://secwatch.observer/filing/0001899883-26-000023.md
- text_url
- https://secwatch.observer/filing/0001899883-26-000023.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1899883/000189988326000023/0001899883-26-000023-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1899883/000189988326000023/ftai-20260507.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
ARTV
Artiva reports 71% ACR50 in refractory RA at 6 months, FDA alignment for Phase 3 trial; Q1 net loss $23.5M
Artiva Biotherapeutics, Inc.
May 8, 2026, 7:59 PM ET
other_material
Items 2.02, 7.01, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: other_material
similar materiality
This filing
per share data) Selected Financial Results Q1’26 Net Loss Attributable to Stockholders, Before Series B Preferred Stock Dividend and Loss on Extinguishment of Preferred Stock $ (150,172) Basic and Diluted Loss per Share of Common Stock $ (1.32) Adjusted EBITDA (1) $ 70,592 Adjusted EBITDA - Four core segments (1)(2) $ 78,760 _______________________________ (1)
Comparable filing
Artiva Biotherapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended March 31, 2026.
Filing page
SEC filing
KOP
Koppers conditionally plans to shut Stickney, IL chemical operations; Q1 adjusted EPS down 19.7%
Koppers Holdings Inc.
May 8, 2026, 7:59 PM ET
other_material
Items 2.02, 2.05, 5.02, 5.07, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: other_material
similar materiality
This filing
per share data) Selected Financial Results Q1’26 Net Loss Attributable to Stockholders, Before Series B Preferred Stock Dividend and Loss on Extinguishment of Preferred Stock $ (150,172) Basic and Diluted Loss per Share of Common Stock $ (1.32) Adjusted EBITDA (1) $ 70,592 Adjusted EBITDA - Four core segments (1)(2) $ 78,760 _______________________________ (1)
Comparable filing
McGuireQT@koppers.com Koppers Holdings Inc. 436 Seventh Avenue Pittsburgh, PA 15219-1800 Tel 412 227 2001 www.koppers.com KOPPERS REPORTS FIRST QUARTER 2026 RESULTS • Sales of $455.3 million vs. $456.5 million in Prior Year Quarter • Net income (loss) of $7.1 million vs. $(13.9) million in Prior Year Quarter • Diluted EPS of $0.35 vs. $(0.68) in Prior Year Quarter •
Filing page
SEC filing
LMFA
LM Funding April Bitcoin production flat at 9.4 BTC; HODL slips to 334.0
LM FUNDING AMERICA, INC.
May 11, 2026, 7:59 PM ET
other_material
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: other_material
This filing
per share data) Selected Financial Results Q1’26 Net Loss Attributable to Stockholders, Before Series B Preferred Stock Dividend and Loss on Extinguishment of Preferred Stock $ (150,172) Basic and Diluted Loss per Share of Common Stock $ (1.32) Adjusted EBITDA (1) $ 70,592 Adjusted EBITDA - Four core segments (1)(2) $ 78,760 _______________________________ (1)
Comparable filing
LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today announced its preliminary, unaudited Bitcoin mining and operational update for the month ended April 30, 2026.
Filing page
SEC filing
GMRS
GMR Solutions Q1 revenue $1.46B (+6.6% YoY), net income $106M (+180% YoY), guides FY26 rev $5.9-6.2B
GMR Solutions Inc.
June 1, 2026, 4:45 PM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
similar materiality
This filing
per share data) Selected Financial Results Q1’26 Net Loss Attributable to Stockholders, Before Series B Preferred Stock Dividend and Loss on Extinguishment of Preferred Stock $ (150,172) Basic and Diluted Loss per Share of Common Stock $ (1.32) Adjusted EBITDA (1) $ 70,592 Adjusted EBITDA - Four core segments (1)(2) $ 78,760 _______________________________ (1)
Comparable filing
today announced financial results for the first quarter ended March 31, 2026, and full year 2026 financial guidance. First Quarter 2026 Financial Highlights ● Net revenue of $1,457.6 million, up 6.6% compared to $1,367.4 million in the first quarter of 2025 ● Net income of $106.3 million, up 179.7% compared to $38.0 million in the first quarter of 2025 ● Adjusted
Filing page
SEC filing
HPE
HPE Q2 FY26: record revenue $10.7B (+40%), raises FY26 guidance, introduces FY27 framework
Hewlett Packard Enterprise Co
June 1, 2026, 4:09 PM ET
earnings
Items 1.01, 2.02, 5.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
similar materiality
This filing
per share data) Selected Financial Results Q1’26 Net Loss Attributable to Stockholders, Before Series B Preferred Stock Dividend and Loss on Extinguishment of Preferred Stock $ (150,172) Basic and Diluted Loss per Share of Common Stock $ (1.32) Adjusted EBITDA (1) $ 70,592 Adjusted EBITDA - Four core segments (1)(2) $ 78,760 _______________________________ (1)
Comparable filing
gross margin, and non-GAAP diluted net EPS, as well as its highest-ever free cash flow generation for a second quarter. Second Quarter Fiscal 2026 Financial Results • Revenue : $10.7 billion, up 40% from the prior-year period • Gross margins : ◦ GAAP of 36.5%, up 810 basis points from the prior-year period and up 60 basis points sequentially ◦ Non-GAAP (1) of 36.9%,
Filing page
SEC filing
CRDO
Credo Q4 revenue $437M (+157% YoY); guides Q1 $465-475M; CEO awarded 1.44M performance-based RSUs
Credo Technology Group Holding Ltd
June 1, 2026, 4:08 PM ET
earnings
Items 2.02, 5.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
similar materiality
This filing
per share data) Selected Financial Results Q1’26 Net Loss Attributable to Stockholders, Before Series B Preferred Stock Dividend and Loss on Extinguishment of Preferred Stock $ (150,172) Basic and Diluted Loss per Share of Common Stock $ (1.32) Adjusted EBITDA (1) $ 70,592 Adjusted EBITDA - Four core segments (1)(2) $ 78,760 _______________________________ (1)
Comparable filing
On June 1, 2026, Credo Technology Group Holding Ltd (the "Company") issued a press release announcing its financial results for the fiscal year ended May 2, 2026.
Filing page
SEC filing
URG
Ur-Energy Q1 2026: pounds captured up 41% QoQ, avg price $70.98, Shirley Basin commenced
UR-ENERGY INC
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
similar materiality
This filing
per share data) Selected Financial Results Q1’26 Net Loss Attributable to Stockholders, Before Series B Preferred Stock Dividend and Loss on Extinguishment of Preferred Stock $ (150,172) Basic and Diluted Loss per Share of Common Stock $ (1.32) Adjusted EBITDA (1) $ 70,592 Adjusted EBITDA - Four core segments (1)(2) $ 78,760 _______________________________ (1)
Comparable filing
a 14% increase over Q4 2025 and a 13% increase over Q1 2025. Financial Performance ◾ Contracted Sales: We sold 55,000 produced pounds of U 3 O 8 as anticipated, generating $3.9 million in revenue, with a majority of our 2026 deliveries scheduled for the latter part of the year to complement the ramp-up and start-up schedules of Lost Creek and Shirley Basin. ◾
Filing page
SEC filing
ACH
Accendra Health Q1 revenue $627.8M, adj. EBITDA $58.4M; >$1.5B debt optimization
ACCENDRA HEALTH INC/VA/
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
similar materiality
This filing
per share data) Selected Financial Results Q1’26 Net Loss Attributable to Stockholders, Before Series B Preferred Stock Dividend and Loss on Extinguishment of Preferred Stock $ (150,172) Basic and Diluted Loss per Share of Common Stock $ (1.32) Adjusted EBITDA (1) $ 70,592 Adjusted EBITDA - Four core segments (1)(2) $ 78,760 _______________________________ (1)
Comparable filing
Commission this morning. Details on First Quarter 2026 Results First Quarter Results (1) ($ in millions, except per share data) 1Q26 1Q25 Net Revenue $ 627.8 $ 673.9 Loss from continuing operations, net of tax, GAAP $ (6.5) $ (3.8) Adj. net (loss) income from continuing operations, Non-GAAP $ (3.1) $ 23.2
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.